Alvotech (ALVO) Equity Income (2021 - 2023)
Alvotech's (ALVO) quarterly Equity Income came in at -$3.2 million in Q4 2023, down 150.39% on a YoY basis from $6.3 million in Q4 2022, and down 17.15% quarter-over-quarter from -$2.7 million in Q3 2023.
Analysis
Alvotech (ALVO) Equity Income (2021 - 2023) Analysis & Trends
Alvotech (ALVO) has reported Equity Income for 3 consecutive years, with -$3.2 million the latest figure, recorded in Q4 2023.
- For the quarter ending Q4 2023, Equity Income fell 150.39% year-over-year to -$3.2 million; the trailing twelve-month figure through Dec 2023 stood at -$14.6 million (down 283.65% YoY), and the FY2023 full-year result was -$7.2 million, down 176.18% from the prior year.
- Equity Income eased to -$3.2 million in Q4 2023 per ALVO's latest filing, from -$2.7 million in the prior quarter.
- Across five years, Equity Income topped out at $1.3 million in Q2 2022 and bottomed at -$7.2 million in Q1 2023.
- Historically, Equity Income has averaged -$2.2 million across 3 years, with a median of -$2.0 million in 2021.
- The sharpest annual moves came in 2022 and 2023: Equity Income jumped 47.64% in 2022, then plunged 216.47% in 2023.
- Over 3 years, Equity Income stood at -$2.4 million in 2021, then soared by 47.64% to -$1.3 million in 2022, then slumped by 150.39% to -$3.2 million in 2023.
- According to Business Quant data, Equity Income over the past three periods registered -$3.2 million, -$2.7 million, and -$1.5 million for Q4 2023, Q3 2023, and Q2 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | -500,000.00 |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | -84,502.07 |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | - |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | - |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | - |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | NutriBand | 72.57 Mn | 69.15 Mn | 181,874.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -3.17 Mn |
| Aug 31, 2023 | -2.71 Mn |
| Jun 30, 2023 | -1.54 Mn |
| Mar 20, 2023 | -7.15 Mn |
| Dec 31, 2022 | -1.27 Mn |
| Aug 31, 2022 | -1.27 Mn |
| Jun 30, 2022 | 1.32 Mn |
| Mar 20, 2022 | -2.59 Mn |
| Dec 31, 2021 | -2.42 Mn |
| Sep 30, 2021 | -837,000.00 |